NABP2

Across TCGA pan-cancer cohorts, NABP2 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated NABP2 data layer compared with 28 for mass-spec protein and 1 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher NABP2 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated NABP2 expression acts as an unfavorable survival marker, although some lineages such as PDAC and LSCC show a favorable association.

CCRCC, LUAD, and HNSC are the cancer types where NABP2 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	DFS	Quartile	All	0.528	0.917	.002	41	view →
LUAD	OS	Median	II,III,IV	0.344	0.776	.026	4	view →
HNSC	OS	Tertile	All	0.777	0.925	.021	3	view →
PDAC	DFS	Median	IV	0.982	0.234	.049	3	view →
LSCC	DFS	Median	All	0.979	0.903	.036	2	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

NABP2–CCRCC (DFS)

Open the CCRCC breakdown →